9 Patents
- US125839142026Methods of Treating Allergy Using Anti-bet V 1 Antibodies
REGENERON PHARMACEUTICALS, Inc.
0 cites - US124417972025Anti-fc Ε-r1 Α (fcϵr1α) Antibodies, Bispecific Antigen-binding Molecules That Bind Fcϵr1α and CD3, and Uses Thereof
Regeneron Pharmaceuticals, Inc.
0 cites - 0 cites
- US118979452024Methods of Treating Allergy Using Anti-bet V 1 Antibodies
REGENERON PHARMACEUTICALS, Inc.
0 cites - US118665032024Methods for Treating Inflammatory Conditions of the Airway or Lungs by Administering Antagonist Monoclonal Antibodies to Interleukin-33 and Interleukin-4 Receptor
Regeneron Pharmaceuticals, Inc.
0 cites - 0 cites
- US115781272023Anti-fc Epsilon-r1 Alpha (fcεr1α) Antibodies, Bispecific Antigen-binding Molecules That Bind Fcεr1α and CD3, and Uses Thereof
Regeneron Pharmaceuticals, Inc.
0 cites - 0 cites